Companies in #Hepatitis
Found 1 company operating in this sector.
EIT Pharma
PrivateBiopharmaceutical company developing lonafarnib for chronic hepatitis delta (HDV), a serious liver infection. NDA accepted by FDA in 2026.
Found 1 company operating in this sector.
Biopharmaceutical company developing lonafarnib for chronic hepatitis delta (HDV), a serious liver infection. NDA accepted by FDA in 2026.